Cargando…
The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis
BACKGROUND: OnabotulinumtoxinA has been shown to reduce headache-days among patients with chronic migraine (CM). The objective of this analysis was to determine whether onabotulinumtoxinA has an impact on headache-day severity in patients with CM among those patients who were deemed non-responders b...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Milan
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539058/ https://www.ncbi.nlm.nih.gov/pubmed/28766236 http://dx.doi.org/10.1186/s10194-017-0784-4 |